Coverage
Filings
Danish biosolutions company Novonesis on Thursday raised its full-year sales forecast after reporting strong growth for the first nine months of the year, citing a robust performance across its markets.
Novonesis on Wednesday laid out new long-term financial targets, aiming to accelerate sales growth and expand profit margins through 2030 as part of its new ‘GROW’ strategy.
Novonesis has successfully completed its acquisition of dsm-firmenich's share of the Feed Enzyme Alliance, the company announced.
| 28 Aug 2025 |
| Trading by management and close relations of management | 22 Aug 2025 |
| Trading by management and close relations of management | 22 Aug 2025 |
| 2030 financial targets announced: Organic sales growth acceleration, margin expansion and ROIC improvement | 20 Aug 2025 |
| Major shareholder announcement | 21 Jul 2025 |